82 related articles for article (PubMed ID: 10199774)
1. Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.
Borson-Chazot F; Serusclat A; Kalfallah Y; Ducottet X; Sassolas G; Bernard S; Labrousse F; Pastene J; Sassolas A; Roux Y; Berthezène F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1329-33. PubMed ID: 10199774
[TBL] [Abstract][Full Text] [Related]
2. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
3. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
Soares DV; Spina LD; de Lima Oliveira Brasil RR; da Silva EM; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency.
Colao A; Di Somma C; Rota F; Pivonello R; Savanelli MC; Spiezia S; Lombardi G
J Clin Endocrinol Metab; 2005 Apr; 90(4):2056-62. PubMed ID: 15671089
[TBL] [Abstract][Full Text] [Related]
5. Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement.
Colao A; Di Somma C; Rota F; Di Maio S; Salerno M; Klain A; Spiezia S; Lombardi G
J Clin Endocrinol Metab; 2005 May; 90(5):2659-65. PubMed ID: 15713715
[TBL] [Abstract][Full Text] [Related]
6. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
Oliveira JL; Aguiar-Oliveira MH; D'Oliveira A; Pereira RM; Oliveira CR; Farias CT; Barreto-Filho JA; Anjos-Andrade FD; Marques-Santos C; Nascimento-Junior AC; Alves EO; Oliveira FT; Campos VC; Ximenes R; Blackford A; Parmigiani G; Salvatori R
J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
[TBL] [Abstract][Full Text] [Related]
7. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
8. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
Szczepańiska Kostro J; Tołwińska J; Urban M; Gardziejczyk M; Głowińska B
J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
Pfeifer M; Verhovec R; Zizek B; Prezelj J; Poredos P; Clayton RN
J Clin Endocrinol Metab; 1999 Feb; 84(2):453-7. PubMed ID: 10022400
[TBL] [Abstract][Full Text] [Related]
10. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
Colao A; Di Somma C; Spiezia S; Rota F; Pivonello R; Savastano S; Lombardi G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
[TBL] [Abstract][Full Text] [Related]
11. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
12. Arrest of atherosclerosis progression after interruption of GH replacement in adults with congenital isolated GH deficiency.
Araujo VP; Aguiar-Oliveira MH; Oliveira JL; Rocha HM; Oliveira CR; Rodrigues TM; Nunes MA; Britto IM; Ximenes R; Barreto-Filho JA; Meneguz-Moreno RA; Pereira RM; Valença EH; Oliveira-Neto LA; Vicente TA; Blackford A; Salvatori R
Eur J Endocrinol; 2012 Jun; 166(6):977-82. PubMed ID: 22416078
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency.
Colao A; Di Somma C; Spiezia S; Savastano S; Rota F; Savanelli MC; Lombardi G
J Clin Endocrinol Metab; 2008 Sep; 93(9):3416-24. PubMed ID: 18593773
[TBL] [Abstract][Full Text] [Related]
14. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.
Attanasio AF; Lamberts SW; Matranga AM; Birkett MA; Bates PC; Valk NK; Hilsted J; Bengtsson BA; Strasburger CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):82-8. PubMed ID: 8989238
[TBL] [Abstract][Full Text] [Related]
15. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters.
Lanes R; Soros A; Flores K; Gunczler P; Carrillo E; Bandel J
J Clin Endocrinol Metab; 2005 Jul; 90(7):3978-82. PubMed ID: 15870123
[TBL] [Abstract][Full Text] [Related]
16. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
Johannsson G; Albertsson-Wikland K; Bengtsson BA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
[TBL] [Abstract][Full Text] [Related]
18. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
Underwood LE; Attie KM; Baptista J;
J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
[TBL] [Abstract][Full Text] [Related]
20. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
Norrman LL; Johannsson G; Sunnerhagen KS; Svensson J
J Clin Endocrinol Metab; 2008 Jul; 93(7):2531-8. PubMed ID: 18397981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
